Former NFL pro Chris Maragos wins $43.5 million medical malpractice claim

Published Date: 02 Mar 2023

The legal team said the jury's decision could make medics think twice before allowing the injured to return to the field.

Read Full News

Latest News

Incision Site May Affect Hernia Risk After Prostate Surgery

Abdominal incisions made to the side are linked to a lower risk for incisional hernia after robotic removal of the prostate than incisions made above the belly button.

Sentinel Node Biopsy Gains Ground in Endometrial Cancer

Sentinel-based lymph node procedures for endometrial cancer staging rise, while systematic lymphadenectomy rates fall by nearly half between 2018 and 2022.

Vulvar Surgery Boosts Sexual Function in Lichen Sclerosus

Surgical correction of vulvar scarring in patients with lichen sclerosus reduced sexual distress and improved function, with most reporting significant pain relief and enhanced clitoral sensation.

Can Endoscopic Mastectomy Reduce Visible Scarring?

A hidden-incision approach may reduce visible scarring and support immediate breast reconstruction while preserving oncologic outcomes in appropriately selected patients.

GSK, Hansoh's Bone Cancer Drug Meets Main Goal in Late-stage Trial

GSK on Tuesday said partner Hansoh Pharmaceutical's experimental drug met the main goal ⁠of keeping an aggressive bone cancer from worsening in a late-stage trial, boosting...

Liberalized Diet Fails to Match Neutropenic Safety

Dr Maurie Markman discusses why modifying cancer diets without RCT data poses major risks, highlighting a trial halted due to a 10% spike in serious infections.

Todays Updates

Freeman’s Lobotomy to Deep Brain Stimulation: What Changed?

The history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.

Wide Variation Seen in Lung Screening False-Positive Rates

US radiologists vary substantially in their reading of low-dose CT lung cancer screens, highlighting a need for measures to help standardize interpretation.

AVD Chemo Regimen Shows Promise in Older Patients With HL

Researchers compare first-line chemotherapy regimens in older patients with classical Hodgkin lymphoma to assess whether AVD is associated with better outcomes in routine care.

Do High-Risk Features of Prostate Cancer Boost HT Benefit?

Researchers analyze individual patient data from five randomized phase 3 trials comparing PORT alone vs PORT plus hormone therapy in patients with recurrent prostate cancer.

How Low Does PSA Need to Go in Metastatic Prostate Cancer?

A new real-world analysis helps clarify the most informative prognostic PSA benchmark in men with metastatic castration-sensitive prostate cancer.

Tissue-Free ctDNA Strongly Prognostic of Recurrence in TNBC

Tissue-free ctDNA may be comparable to tumor-informed assays in detecting molecular residual disease.

Todays Updates

Freeman’s Lobotomy to Deep Brain Stimulation: What Changed?

The history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.

Wide Variation Seen in Lung Screening False-Positive Rates

US radiologists vary substantially in their reading of low-dose CT lung cancer screens, highlighting a need for measures to help standardize interpretation.

AVD Chemo Regimen Shows Promise in Older Patients With HL

Researchers compare first-line chemotherapy regimens in older patients with classical Hodgkin lymphoma to assess whether AVD is associated with better outcomes in routine care.

Do High-Risk Features of Prostate Cancer Boost HT Benefit?

Researchers analyze individual patient data from five randomized phase 3 trials comparing PORT alone vs PORT plus hormone therapy in patients with recurrent prostate cancer.

How Low Does PSA Need to Go in Metastatic Prostate Cancer?

A new real-world analysis helps clarify the most informative prognostic PSA benchmark in men with metastatic castration-sensitive prostate cancer.

Tissue-Free ctDNA Strongly Prognostic of Recurrence in TNBC

Tissue-free ctDNA may be comparable to tumor-informed assays in detecting molecular residual disease.

Latest News

Abdominal incisions made to the side are linked to a lower risk for incisional hernia after robotic removal of the prostate than incisions made above the belly button.

Sentinel-based lymph node procedures for endometrial cancer staging rise, while systematic lymphadenectomy rates fall by nearly half between 2018 and 2022.

Surgical correction of vulvar scarring in patients with lichen sclerosus reduced sexual distress and improved function, with most reporting significant pain relief and enhanced clitoral sensation.

A hidden-incision approach may reduce visible scarring and support immediate breast reconstruction while preserving oncologic outcomes in appropriately selected patients.

GSK on Tuesday said partner Hansoh Pharmaceutical's experimental drug met the main goal ⁠of keeping an aggressive bone cancer from worsening in a late-stage trial, boosting...

Dr Maurie Markman discusses why modifying cancer diets without RCT data poses major risks, highlighting a trial halted due to a 10% spike in serious infections.

News All Time

Massive Medical Equipment Warehouse Burns Down

Officials say sprinklers at California facility didn't work during blaze

Q&A: Can More Patients With MIBC Keep Their Bladder?

Rapid developments in muscle-invasive bladder cancer treatment are leading to new approaches to bladder preservation.

Do HIV, Organ Transplant Raise Odds of HPV-Related Cancers?

A study evaluates whether people with HIV infection and solid organ transplant recipients have higher odds of HPV-related cancers than unexposed control individuals.

Man Diagnosed With Ehrlichiosis After Heart Transplant

A heart transplant recipient developed fever, confusion, and worsening cytopenias before an unexpected tick-borne infection was identified and treated successfully.

Aesthetic Medicine

Aesthetic Medicine : The Aesthetic Medicine News & Perspectives presents the latest information on anti-aging treatments, injectable and implantable soft tissue fillers, botulinum toxin treatments, laser surgery, and other treatments to repair and improve the function and cosmetic appearance of skin tissue.

PET-CT Linked to Improved Margin Assessment in Breast Cancer

Researchers compare success rates for addressing positive margins without intraoperative margin assessment with specimen PET-CT in patients with invasive ductal carcinoma.

Water Ablation Shows Early Promise for Prostate Cancer

Early findings show efficacy of water vapor therapy for treating intermediate-risk prostate cancer with minimal procedural complications.

Vacuum-Tech May Improve Outcomes of Kidney Stone Surgery

Vacuum-assisted flexible ureteroscopy may help clear large kidney stones as well as or better than mainstay treatments, with favorable outcomes after surgery.

Patient Requests That Can Put You In a Tough Position

Requests for emotional support animals, disabled parking placards, and, more recently, Medicaid work exemptions can prove challenging for physicians. Here’s what you need to know.

Europe’s Medical Loophole for Banned Doctors

A doctor struck off in France kept practicing in Belgium, exposing how gaps in EU medical oversight can let sanctioned clinicians cross borders.

Rare Adenoid Cystic Breast Cancer in a Woman

A woman with rare breast adenoid cystic carcinoma carries a BRIP1 variant of uncertain significance, highlighting the challenges in genetic risk assessment.

What the FDA's Hormone Therapy Decision Means for Aging Skin

Skin collagen content decreases at a rate of approximately 1%-2% per year in the early postmenopausal period, skin thickness diminishes, barrier function weakens, and moisture retention falters

US FDA Approves Pfizer's Bleeding Disorder Drug for Children

(Corrects paragraph 2 to say Hympavzi is the first non-factor therapy particularly for pediatric patients with hemophilia ⁠B, not all)

Ask the HF Expert: Advanced Therapies

Dr Yash Varma, a chief cardiology fellow, asks Dr Ileana Piña for her insights on when a patient with heart failure should be referred for advanced therapies.

Selpercatinib Cuts Recurrence Risk in Early RET+ NSCLC

In the first phase 3 trial of a RET inhibitor as adjuvant therapy, selpercatinib markedly improved event-free survival vs placebo in early-stage RET fusion-positive NSCLC.

More Women With Breast Cancer Can Skip Axillary Dissection

The largest randomized trial of its kind to date found noninferior survival and better arm morbidity among patients with breast cancer who did not undergo completion axillary lymph node dissection.

Recommended News For You

Parkinson patient's gait is restored by a spinal cord stimulator.

Pollution exposure may affect lung cancer in women who have never smoked

Screening for prostate cancer: is it time to give up digital rectal examination?

Study confirms link between breast density, higher breast cancer risk

Scientists discover the 'roadmap' that aggressive cancer uses to spread

Experts Discuss Groundbreaking Advances in EGFR-Mutant Lung Cancer

High Fruit, Veggie Diet Tied to Early-Onset Lung Cancer?

Recommended Articles For You

Macrocytic Anemia: A Comprehensive Review of Pathophysiology, Diagnosis, and Clinical Management 

Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care 

Importance of Early Detection in Hematology 

Comprehensive Standards in Oncology for Modern Medicine 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The clinical trial of ENZAMET shows promise as a treatment for prostate cancer.

2.

Advanced breast cancer patients living longer thanks to improvements in treatment and care

3.

Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.

4.

Induction Immunotherapy Has Durable Survival Benefit in LACC

5.

Cognitive Bias Modification App Fosters Alcohol Avoidance

1.

Everything You Need to Know About HTLV: A Comprehensive Guide 

2.

Environmental Carcinogen Exposure Risk Modeling: Current Evidence and Clinical Implications

3.

Unlocking the Unknown: A Comprehensive Guide to Stage 4 Vulvar Cancer

4.

Minimal Residual Disease Monitoring: Advances, Clinical Relevance, and Guideline-Based Perspectives

5.

Practical Developments in Hematology in the Digital Era

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

1.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

2.

Updates on Standard V/S High Risk Myeloma Treatment

3.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII

5.

Current Scenario of Cancer- Palliative Care to Close the Care Gap

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot